BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruan H, Wang T, Yang C, Jin G, Gu D, Deng X, Wang C, Qin W, Jin H. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma. Sci Rep 2016;6:32421. [PMID: 27581744 DOI: 10.1038/srep32421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Brachtendorf S, El-hindi K, Grösch S. Ceramide synthases in cancer therapy and chemoresistance. Progress in Lipid Research 2019;74:160-85. [DOI: 10.1016/j.plipres.2019.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
2 Huang L, Luan T, Chen Y, Bao X, Huang Y, Fu S, Wang H, Wang J. LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells. J Cancer 2018;9:1017-24. [PMID: 29581781 DOI: 10.7150/jca.23087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fu S, Luan T, Jiang C, Huang Y, Li N, Wang H, Wang J. miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2. Gene 2019;701:23-31. [PMID: 30898713 DOI: 10.1016/j.gene.2019.02.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Peng L, Yuan XQ, Zhang CY, Ye F, Zhou HF, Li WL, Liu ZY, Zhang YQ, Pan X, Li GC. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients. Oncotarget 2017;8:34387-97. [PMID: 28415739 DOI: 10.18632/oncotarget.16166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Brachtendorf S, El-Hindi K, Grösch S. WITHDRAWN: Ceramide synthases in cancer therapy and chemoresistance. Prog Lipid Res 2019;:100992. [PMID: 31442523 DOI: 10.1016/j.plipres.2019.100992] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Zhang Q, Wang JY, Yan W, Wang DD, Yang SJ, Zhou SY, Zhong SL, Tang JH. Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers. Biosci Rep 2019;39:BSR20181743. [PMID: 30988071 DOI: 10.1042/BSR20181743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Huang Y, Wang H, Fu S, Luan T, Zuo Y, Li N, Ding M, Chen Y, Wang J. Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population. Eur J Cancer Prev 2020;29:329-37. [PMID: 31577563 DOI: 10.1097/CEJ.0000000000000551] [Reference Citation Analysis]
8 Jin H, Wang C, Gu D, Zhang Y, Fan S, Xing S, Wang H, Ruan H, Yang C, Lv Y, Feng H, Yao M, Qin W. Liver-specific deletion of LASS2 delayed regeneration of mouse liver after partial hepatectomy. Biochem Biophys Res Commun 2017;493:1176-83. [PMID: 28958935 DOI: 10.1016/j.bbrc.2017.09.128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]